The Impact of an Antibiotic (Cefazolin) Before Surgery on the Microbiome in Patients With Stage I-II Melanoma
Status:
Recruiting
Trial end date:
2021-05-31
Target enrollment:
Participant gender:
Summary
This phase I trial investigates the impact of cefazolin before surgery on the microbiome in
patients with stage I-II melanoma. Antibiotics, such as cefazolin, given at the time of
surgery may cause a significant change in the microbes (like bacteria and viruses) found in
the stomach and intestines. This trial may help researchers learn if any changes in microbes
affect the body's ability to respond to surgery and cancer.